IRIS
CUCINOTTA, Domenico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.108
EU - Europa 6.183
AS - Asia 1.203
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 4
OC - Oceania 1
Totale 14.518
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.091
IE - Irlanda 1.865
SE - Svezia 1.558
CN - Cina 1.056
UA - Ucraina 676
DE - Germania 639
IT - Italia 469
FI - Finlandia 333
GB - Regno Unito 247
FR - Francia 195
IN - India 99
BE - Belgio 47
PL - Polonia 39
AT - Austria 31
RU - Federazione Russa 31
CA - Canada 16
IR - Iran 16
CH - Svizzera 12
NL - Olanda 9
BR - Brasile 8
ES - Italia 7
EU - Europa 6
KR - Corea 5
CL - Cile 4
JP - Giappone 4
LV - Lettonia 4
VN - Vietnam 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
LU - Lussemburgo 3
MY - Malesia 3
DK - Danimarca 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
MA - Marocco 2
RO - Romania 2
SG - Singapore 2
TR - Turchia 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
EE - Estonia 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 14.518
Salva come PNG Salva come JPEG
Città #
Dublin 1.863
Jacksonville 1.434
Chandler 1.268
Nyköping 762
Beijing 424
Ashburn 342
Princeton 340
Cambridge 331
Dearborn 300
Des Moines 267
Medford 257
Ann Arbor 195
Boardman 163
Bremen 143
Messina 133
New York 97
Jinan 95
Woodbridge 91
San Mateo 88
Wilmington 85
Shenyang 84
Lancaster 77
Pune 61
Nanjing 50
Brussels 46
Hebei 42
Zhengzhou 39
Warsaw 37
Tianjin 35
Ningbo 34
Vienna 31
Haikou 30
Norwalk 30
Hangzhou 29
Los Angeles 26
Taizhou 24
Augusta 22
Houston 22
Nanchang 20
Rome 19
Seattle 18
Leawood 15
Washington 14
Ardabil 13
Auburn Hills 13
Fuzhou 13
Guangzhou 12
Helsinki 12
Hyderabad 12
Milan 12
Changsha 11
Jiaxing 11
Lanzhou 11
Monmouth Junction 11
Taiyuan 11
Hefei 10
Saint Petersburg 9
Catania 8
Edinburgh 8
Mumbai 8
Ottawa 8
Torino 8
Bologna 7
Falls Church 7
Strasbourg 7
Venezia 7
Clearwater 6
Rende 6
Turin 6
Zurich 6
Belpasso 5
Caserta 5
Chicago 5
Naples 5
Redmond 5
Woking 5
Amsterdam 4
Chaoyang 4
Dong Ket 4
Genova 4
Kemerovo 4
Madrid 4
Napoli 4
Novokuznetsk 4
Palermo 4
Riva 4
Toronto 4
Barletta 3
Cheung Sha Lan 3
Garbagnate Milanese 3
Geneva 3
Las Vegas 3
Luxembourg 3
Modena 3
Nanning 3
Nashville 3
Nuremberg 3
Padova 3
Pioltello 3
Pontaubert 3
Totale 9.849
Salva come PNG Salva come JPEG
Nome #
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). 242
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 105
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 96
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 96
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 86
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 85
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 81
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 78
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 77
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 77
Secrezione insulinica e tolleranza glucidica in dislipidemici e loro modificazioni dopo trattamento ipolipemizzante. 76
Valutazione delle apoproteine A e B, delle lipoproteine e dei lipidi plasmatici durante trattamento con benzafribato in varie forme di iperlipoproteinemia. 75
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 75
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 72
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 71
SERUM URINARY ACTIVITIES OF b-N-ACETYLGLUCOSAMINIDASE AND b-GLUCURONIDASE IN DIABETIC PATIENTS. 71
SU DI UN CASO DI STRONGILOIDIASI AD EVOLUZIONE INFAUSTA 70
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 70
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 70
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 70
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 68
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 66
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 66
SERUM ACTIVITY OF BETA- N-ACETYLGLUCOSAMINIDASE IN OBESE HYPERINSULINEMIC SUBJECTS. 66
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 66
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 66
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 66
Age and metabolic control influence lens opacity in IDDM patients. 65
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse 65
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study 65
Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia 64
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 64
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 64
EFFETTI DI UN BREVE PERIODO DI NORMALIZZAZIONE GLICEMICA SULLA FUNZIONE VENTRICOLARE SINISTRA IN DIABETICI INSULINO-DIPENDENTI. 64
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 64
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 64
Autoantibodies against cytokeratin 19 in patients with type 1 diabetes mellitus 63
A DECREASED BRAIN-STEM CONTENT OF GABA MEDIATES HYPERINSULINEMIA IN OBESE ZUCKER RATS 63
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 63
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 63
Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. 63
RUOLO DELL'IPEROMOCISTEINEMIA E DEL GENOTIPO C677T DEL GENE DELLA METILENE TEDRAIDROFOLATO REDUTTASI (MTHFR)IN UNA POPOLAZIONE DI DIABETICI DI TIPO 2 CON E SENZA SINDROME METABOLICA 62
Anti-p53 autoantibodies in patients with IDDM 62
Valutazione urodinamica computerizzata in diabeti di tipo 2: dati preliminari 62
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 61
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 61
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 60
Serum anti-p53 autoantibodies in patients with type 1 diabetes 60
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 60
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 60
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 60
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 60
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 59
ADULT HEIGHT EXCEEDING TARGET HEIGHT IN A PATIENT WITH CONGENITAL PANHYPOPITUITARISM DIAGNOSED AFTER THE AGE OF 25 YEARS 59
Calcio e secrezione endocrina pancreatica Nota III. Efffetti di una infusione di calcio sulla secrezione glucagonica da ipoglicemia insulinica. 59
Glucose tolerance,insulin secretion and peripheral sensitivity in thalassemia major 58
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 58
LIVELLI DI EMOGLOBINA FETALE IN UNA POPOLAZIONE AMBULATORIALE DI PAZIENTI DIABETICI 58
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 58
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. 58
Increased c-met expression during ductal beta cell neogenesis in experimental autoimmune diabetes 57
Taurine and osmoregulation: Platelet taurine content, uptake, and release in type 2 diabetic patients 57
DINAMICHE DI PERSONALITÀ E QUALITÀ DELLA VITA NEL DIABETE MELLITO TIPO 1, INSULINO-DIPENDENTE 57
Valutazione clinico terapeutica di un trattamento ipolipemizzante con sinfibrato 57
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 57
Altered platetel magnesium and urinary soluble form of intercellular adhesion molecule concentrations in insulin dependent diabetes mellitus patients with microalbuminuria 57
A multicenter study on the prevalence of diabetic neuropathy in Italy 56
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 56
Plasma insulin and glucose time courses following biliary pancreatic diversion: evaluation of two different ways of glucose loading. 56
POLIMORFISMO DEL GENE DELL'APOLIPOPROTEINA E E PATOLOGIA COLELITIASICA IN UNA POPOLAZIONE DEL SUD ITALIA 55
PREVALENCE OF AUTOANTIBODIES TO CARBONIC ANHYDRASE II AND LACTOFERRIN IN PATIENTS WITH TYPE 1 DIABETES 55
Skin lesions in diabetes mellitus: prevalence and clinical correlations. 55
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 55
BETA-CELL FUNCTION, PERIPHERAL SENSITIVITY TO INSULIN AND ISLET CELL AUTOIMMUNITY IN CYSTIC-FIBROSIS PATIENTS WITH NORMAL GLUCOSE-TOLERANCE 54
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 54
Biphasic insulin aspart in the treatment of type 2 diabetes mellitus 54
Correlates of total homocysteine plasma concentration in type 2 diabetes 53
Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. 53
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 53
Incidence of erectile dysfunction in Italian men with diabetes 52
IPEROMOCISTEINEMIA E RISCHIO CARDIOVASCOLARE NEL DIABETE MELLITO 52
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury 52
Cardiovascular effects of raloxifene hydrochloride 52
Associazione del polimorfismo MTHFR C677T con i livelli plasmatici di omocisteina nel diabete mellito di tipo 2: un effetto modulato dai folati e dal sesso 52
La proteina C reattiva in una popolazione ad alto rischio di insorgenza del diabete mellito di tipo 2 52
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 52
L’ETA’ E IL COMPENSO METABOLICO CONDIZIONANO UNA PRECOCE OPACIZZAZIONE DEL CRISTALLINO NEL DIABETE MELLITO INSULINO-DIPENDENTE 52
Age and metabolic control influence lens opacity in IDDM patients 52
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 52
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 52
LE DISLIPIDEMIE NEL PAZIENTE DIABETICO 51
Comparison of the efficacy and safety of three different premixed combinations of biphasic insulin aspart - a randomised controlled clinical trial in subjects with type 2 diabetes 51
“CHLORPROPAMIDE ALCOOL FLUSHING TEST” E DIABETE MELLITO: STUDIO EPIDEMIOLOGICO E CLINICO. G. Ital. Diabetol. 3:297-301,1983 51
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 51
determinants of total homocysteine plasma levels in type 2 diabetes 51
THE ITALIAN MULTICENTRE STUDY ON THE PREVALENCE OF DISTAL SYMMETRIC POLYNEUROPATHY: CORRELATION BETWEEN CLINICAL VARIABLES AND NERVE CONDUCTION PARAMETERS. ITALIAN DIABETIC NEUROPATHY COMMITTEE 50
INSULIN SENSITIVITY IN CYSTIC-FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 50
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 50
ELEVATA PREVALENZA DELLA COLONIZZAZIONE DA PARTE DI ARCOBACTER P: IN SOGGETTI ASINTOMATICI CON DIABETE DI TIPO 2. 50
Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major 50
Totale 6.364
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 0 0 11 15
2019/20202.476 386 168 19 137 20 289 353 328 50 299 413 14
2020/20211.856 220 6 481 87 121 252 24 195 20 157 211 82
2021/20222.115 18 269 30 85 53 7 149 88 44 448 266 658
2022/20235.380 429 363 218 401 524 523 38 342 2.296 32 165 49
2023/20241.063 89 219 90 116 94 304 25 71 18 34 3 0
Totale 14.734